Item 5. Market for Registrant’s Common Equity
Item
5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Trading
Equity
Our
shares of Common Stock currently are quoted on Nasdaq under the symbol “EXOZ.” From November 11, 2024, when we completed
our IPO, our Common Stock was quoted on Nasdaq under the symbol “IZTC.” When we changed our corporate name on February 10,
2025, to eXoZymes Inc., the trading symbol was changed to “EXOZ”.
As
of March 16, 2026, we had approximately 577 shareholders of record of the Common Stock and we believe there are additional shareholders that hold their shares in street name.
Distributions
We
have not paid any dividends or made any distributions related to our equity securities, to date.
Whether
any distributions, the kinds of distributions, and the value of distributions are made in the future will depend on many factors and
will be determined by the management of eXoZymes, from time to time. Investors should not look to any distribution that we might make
to be a regular income item in an investor’s portfolio. We anticipate that any income will be retained and used in our operations.
Securities
Authorized for Issuance Under Equity Compensation Plans
Plan category
Number
of securities to be issued upon exercise of outstanding awards
Weighted-average
exercise price of outstanding awards
Number
of securities remaining available for future issuance under equity compensation plans
2020 Equity Incentive Award Plan,
approved by security holders*
2,488,055 **
$ 5.67
34,494
2025 Equity Incentive Award Plan, approved
by security holders*
-
-
-
Equity award plans not
approved by security holders
-
-
-
Total
2,488,055 **
$ 5.67
34,494
*
The 2020 Equity Incentive Award Plan provides awards for up to 2,489,467 shares of shares of Common Stock. As of December 31, 2025,
there are a total of 317,022 shares of Common Stock available for issuance.
**
As of December 31, 2025, of the 2,488,055 securities to be issued upon exercise and vesting of awards, 2,011,269 represent share options
with a weighted average exercise price of $5.67 and 436,786 represent Restricted Stock Unit awards which do not require payment of an
exercise price. The Restricted Stock Unit awards are not included in the calculation of the weighted average exercise price above.
Item
6. [Reserved]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.